The importance of hepatic functional reserve in sequential therapy with molecular targeted agents for advanced hepatocellular carcinoma 1) Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practice 2) Trends in hepatic functional reserve of patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors

アクセス数 : 284
ダウンロード数 : 169

今月のアクセス数 : 0
今月のダウンロード数 : 1
File
k8332_1.pdf 192 KB 種類 : abstract
File
k8332_2.pdf 178 KB 種類 : abstract
File
k8332_3-2.pdf 960 KB 種類 : fulltext エンバーゴ : 2021-11-01
Title ( eng )
The importance of hepatic functional reserve in sequential therapy with molecular targeted agents for advanced hepatocellular carcinoma 1) Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practice 2) Trends in hepatic functional reserve of patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Title ( jpn )
進行肝細胞癌に対する分子標的薬逐次療法における肝予備能の重要性 1)ソラフェニブ不応進行肝細胞癌患者におけるレゴラフェニブ治療適格症例の検討 2)肝細胞癌に対するチロシンキナーゼ阻害剤治療中の予備能推移に関する検討
Creator
Uchikawa Shinsuke
Language
eng
Resource Type doctoral thesis
Rights
1) (c) 2018 The Japan Society of Hepatology
2) This is the accepted manuscript version of an article published by S. Karger AG in Oncology 2020;98(10):727-733 including DOI and available on www.karger.com/Article/FullText/doi. This is not the published version. Please cite only the published version. この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。
Access Rights open access
Source Identifier
Hepatology Research, 2018; 48: 814-820
Oncology, October 2020;98:727-733
[DOI] https://doi.org/10.1111/hepr.13180
[DOI] https://doi.org/10.1159/000507815
Dissertation Number 甲第8332号
Degree Name
Date of Granted 2020-09-18
Degree Grantors
広島大学
Remark 1) の全文は、出版社の規定によりリポジトリでの公開が認められておりませんので、関連情報URLをご覧下さい。2) Post-print version/PDF may be used in an institutional repository after an embargo period of 12 months.